TempraMed Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Public

  • Employees
  • 10

Employees

  • Stock Symbol
  • VIVI

Stock Symbol

  • Share Price
  • $0.22
  • (As of Friday Closing)

TempraMed General Information

Description

TempraMed Technologies Ltd through its subsidiary, engaged in developing patent-protected technology designed to serve a broad range of medical and consumer products. TempraMed's primary focus is revolutionizing storage and management of injectable for temperature-sensitive medications. This inventive technology ensures adequate temperature storage conditions to medications without requiring power source or human intervention for years.

Contact Information

Formerly Known As
GF Greenfield Ventures, GF Greenfield
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 19481 South East 14th Street
  • Sammamish, WA 98075
  • United States
+1 (800)
Primary Industry
Medical Supplies
Other Industries
Therapeutic Devices
Other Devices and Supplies
Stock Exchange
CNQ
Vertical(s)
Corporate Office
  • 19481 South East 14th Street
  • Sammamish, WA 98075
  • United States
+1 (800)

TempraMed Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TempraMed Stock Performance

As of 13-Nov-2026, TempraMed’s stock price is $0.22. Its current market cap is $17.5M with 80.4M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.22 $0.23 $0.17 - $1.02 $17.5M 80.4M 12.5K -$0.27

TempraMed Financials Summary

As of 30-Jun-2026, TempraMed has a trailing 12-month revenue of $1.95M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 33,533 56,794
Revenue 1,947 1,843 2,264 0
EBITDA (20,173) (17,649) (3,004) (3)
Net Income (20,402) (18,191) (3,354) (3)
Total Assets 1,120 1,842 469 0
Total Debt 1,590 1,261 2,517 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

TempraMed Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore TempraMed‘s full profile, request access.

Request a free trial

TempraMed Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore TempraMed‘s full profile, request access.

Request a free trial

TempraMed Patents

TempraMed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12746342-B2 Apparatuses, systems and methods for storing a substance Active 02-Feb-2021
US-20240091458-A1 Apparatuses, systems and methods for storing a substance Active 02-Feb-2021

TempraMed Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TempraMed Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore TempraMed‘s full profile, request access.

Request a free trial

TempraMed ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Commercial Services

Industry

Rank

Percentile

Business Support Services

Subindustry

Rank

Percentile

To view TempraMed’s complete esg history, request access »

TempraMed FAQs

  • When was TempraMed founded?

    TempraMed was founded in 2014.

  • Where is TempraMed headquartered?

    TempraMed is headquartered in Sammamish, WA.

  • What is the size of TempraMed?

    TempraMed has 10 total employees.

  • What industry is TempraMed in?

    TempraMed’s primary industry is Medical Supplies.

  • Is TempraMed a private or public company?

    TempraMed is a Public company.

  • What is TempraMed’s stock symbol?

    The ticker symbol for TempraMed is VIVI.

  • What is the current stock price of TempraMed?

    As of 13-Nov-2026 the stock price of TempraMed is $0.22.

  • What is the current market cap of TempraMed?

    The current market capitalization of TempraMed is $17.5M.

  • What is TempraMed’s current revenue?

    The trailing twelve month revenue for TempraMed is $1.95M.

  • What is TempraMed’s annual earnings per share (EPS)?

    TempraMed’s EPS for 12 months was -$0.27.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process